Hot Features
Premium
Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Período:
Tipo de Línea:
| Volume | 0 |
|
|||||
| Noticias | - | ||||||
| Máximo del Dia | Mínimo Máximo |
||||||
| Minimo del Dia | |||||||
| Nombre de la Acción | Símbolo de la Acción | Bolsa de Valores | Tipo de Valor |
|---|---|---|---|
| Landos Biopharma Inc | LABP | NASDAQ | Acción Común |
| Variación del Día (ptos.) | Variación del Día (%) | Último Precio | Hora
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 22.4799 | 03:00:00 |
| Precio de Apertura | Precio Mínimo | Precio Máximo | Precio de cierre | Precio Anterior |
|---|---|---|---|---|
| 22.4799 |
| Operaciones | Volume Operado de la Acción | Volumen promedio | Rango 52 semanas |
|---|---|---|---|
| 0 | 0 | - | 2.50 - 22.84 |
| Último Operado | Tipo de Operación | Cantidad Operada | Precio Operado | Divisa |
|---|---|---|---|---|
| - | 0 | US$ 22.4799 | USD |
Información Financiera Landos Biopharma Inc LABP
| Capitalización de Mercado [m] | Acciones en circulación | Float | Ingresos | Ganancia/Pérdida | Utilidad por Acción (UPA) | Ratio Precio/Utilidad |
|---|---|---|---|---|---|---|
| 70.06M | 3.12M | - | 0 | -21.94M | -7.04 | - |
| Interés de corto | Dividendos Por Acción | Rendimiento del Dividendo | Fecha esperada de dividendos | Transacciones ejecutivas | % de acciones controladas por todos los ejecutivos y 5% propietarios: |
|---|---|---|---|---|---|
| - | - | - | - |
Noticias sobre Landos Biopharma Inc LABP
| Fecha | Hora | Fuente | Noticias Artículo |
|---|---|---|---|
| 25/3/2024 | 07:31 | PR Newswire (US) | AbbVie to Acquire Landos Biopharma, Further Strengthening.. |
| 25/3/2024 | 07:30 | GlobeNewswire Inc. | AbbVie to Acquire Landos Biopharma, Further Strengthening.. |
| 04/3/2024 | 15:14 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
| 04/3/2024 | 15:06 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
| 14/2/2024 | 15:01 | Edgar (US Regulatory) | Form SC 13G/A - Statement of acquisition of beneficial.. |
| 04/1/2024 | 07:05 | Edgar (US Regulatory) | Form 8-K - Current report |
| 21/11/2023 | 07:08 | Edgar (US Regulatory) | Form 8-K - Current report |
| 09/11/2023 | 07:22 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
| 09/11/2023 | 07:08 | Edgar (US Regulatory) | Form 8-K - Current report |
| 21/9/2023 | 07:00 | Edgar (US Regulatory) | Form 8-K - Current report |
| 14/9/2023 | 07:11 | Edgar (US Regulatory) | Form 8-K - Current report |
| 09/8/2023 | 07:18 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
Histórico de Datos LABP
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 21.90 | 22.84 | 21.90 | 22.28 | 8,215 | 0.5799 | 2.65% |
| 1 Month | 21.60 | 22.84 | 21.43 | 21.65 | 18,812 | 0.8799 | 4.07% |
| 3 Months | 5.45 | 22.84 | 4.83 | 17.61 | 26,335 | 17.03 | 312.48% |
| 6 Months | 3.88 | 22.84 | 3.21 | 14.07 | 16,673 | 18.60 | 479.38% |
| 1 Year | 2.847 | 22.84 | 2.50 | 8.01 | 19,166 | 19.63 | 689.60% |
| 3 Years | 114.40 | 161.70 | 2.111 | 19.23 | 126,794 | -91.92 | -80.35% |
| 5 Years | 130.00 | 169.89 | 2.111 | 34.42 | 136,322 | -107.52 | -82.71% |
